Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
8.96
+0.02 (0.22%)
At close: Dec 31, 2025, 4:00 PM EST
8.89
-0.07 (-0.78%)
After-hours: Dec 31, 2025, 7:51 PM EST
Nuvation Bio Market Cap
Nuvation Bio has a market cap or net worth of $3.07 billion as of December 31, 2025. Its market cap has increased by 249.69% in one year.
Market Cap
3.07B
Enterprise Value
2.58B
1-Year Change
249.69%
Ranking
Category
Stock Price
$8.96
Market Cap Chart
Since August 26, 2020, Nuvation Bio's market cap has increased from $174.48M to $3.07B, an increase of 1,660.55%. That is a compound annual growth rate of 70.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 3.07B | 243.11% |
| Dec 31, 2024 | 895.27M | 170.80% |
| Dec 29, 2023 | 330.61M | -21.16% |
| Dec 30, 2022 | 419.31M | -77.35% |
| Dec 31, 2021 | 1.85B | 779.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 26, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 966.79B |
| Johnson & Johnson | 498.51B |
| AbbVie | 406.04B |
| UnitedHealth Group | 300.88B |
| AstraZeneca | 287.28B |
| Novartis AG | 266.00B |
| Merck & Co. | 263.24B |
| Novo Nordisk | 227.63B |